Similar to our Access Funds — a one-and-done portfolio of emerging startups — focused on a specific technology or disease areas, such as longevity, digital health, oncology, neuro, and more — each managed by our experienced investment professionals.
Bioverge is launching a series of Thematic Funds, sign up now to be notified for your next opportunity to outperform with one of our Thematic Funds1.
Leverage Bioverge’s decades of institutional experience and broad healthcare-focused network and invest alongside leading world-class venture capital firms, institutions, and other professional investors.
Invest in a diversified portfolio of emerging healthcare startups around a specific technology or disease area to build wealth more efficiently.
Are you interested in longevity, cancer, neurodegenerative diseases, or AI? If so, our Thematic Funds may be for you.
Access a portfolio carefully constructed to outperform by seasoned healthcare investment professionals. Each opportunity undergoes a specialized diligence review leveraging subject matter expertise and requiring professional co-investor participation.
Invest in a healthcare venture capital fund that reduces barriers to institutional-quality assets more efficiently and with low fees.
Invest alongside top-tier venture funds, at the same terms.
We do the heavy lifting. With a single investment, the Bioverge professionals will build you a diversified portfolio of emerging healthcare investments with unique potential for both outsized investment returns and outsized impact on the world.
Bioverge Funds have preferred access to all Bioverge deals, including pro-rata and special one-time opportunities. Fund investors also enjoy discounted fees when participating directly on a deal-by-deal basis.
Click here to learn more about our flagship fund, the Bioverge Access Fund (now open to investors)
Bioverge Funds allow investors to access 15 or more companies via a single investment. Our Bioverge Deal-by-Deal products, by comparison, typically invest in a single deal/company. Diversification is a benefit of the Bioverge Funds, as investment risk may be spread across multiple assets. Additionally, investors in Bioverge Funds can access healthcare venture capital opportunities on a wider scale than they might otherwise be able to by making individual investments.
Once you create an account, you will be able to review our investment opportunities. Once you’re ready to invest, our platform will prompt you with any questions necessary to complete your investment documents online and how to fund your investments.As an investor, you will have access to your portfolio details and you will receive quarterly updates on how your investments are performing. If an investment exit is realized, you will receive associated distribution income or public shares.
Yes, international investors can participate in Bioverge Funds. Our offerings are conducted under the SEC's Regulation D, Rule 506, which allows for participation from both domestic and international investors, provided that they are accredited and comply with the regulations of their respective jurisdictions.
Each Bioverge Fund is a limited liability company (LLC) that invests in private securities offerings and is managed by Bioverge. We act as the decision-maker on your behalf, handling the day-to-day operations. As a Bioverge Fund investor, your investment is held in the form of ownership interest in the LLC. If something were to happen to Bioverge (the company), you would still maintain your ownership of the LLC and the entity’s underlying investment holdings.